The drug company’s decision will affect around 1.5 million teenage girls in Africa who, as a result, will lose their chance to avoid cervical cancer in the near future.
Mr Yakubu said sensitisation was ongoing at the national level, but he can’t say anything about Kogi.
Mr Pate added that cervical cancer is the third most common cancer and the second most frequent cause of cancer deaths among women in Nigeria.
“The vaccine is expensive but the government is making it available for pre-teen girls for free,” she said.
The NPHCDA boss said the children never received any form of vaccination effort.
